Odyssey Health, Inc. (OTCMKTS:ODYY – Get Free Report) saw a significant drop in short interest in October. As of October 15th, there was short interest totaling 29,561 shares, a drop of 50.8% from the September 30th total of 60,061 shares. Based on an average trading volume of 40,904 shares, the days-to-cover ratio is currently 0.7 days.
Odyssey Health Trading Up 22.9%
Shares of ODYY traded up $0.00 during mid-day trading on Friday, reaching $0.01. 1,705,351 shares of the stock traded hands, compared to its average volume of 169,815. The stock has a fifty day simple moving average of $0.01 and a 200 day simple moving average of $0.03. Odyssey Health has a 12-month low of $0.00 and a 12-month high of $0.08.
Odyssey Health Company Profile
Odyssey Health, Inc, formerly known as Odyssey Group International, Inc, is a medical technology and pharmaceutical development company focused on products for neurological and other serious health conditions. The company’s work includes drug candidates and medical devices intended to address unmet needs in brain health.
Odyssey Health’s principal development program is ONP-002, an intranasal drug candidate being developed for the treatment of concussion and traumatic brain injury. The company has stated that the product is designed to deliver treatment directly to the brain through the nasal passage and may help address the effects of brain injury.
Read More
- Five stocks we like better than Odyssey Health
- Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
Receive News & Ratings for Odyssey Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Odyssey Health and related companies with MarketBeat.com's FREE daily email newsletter.
